SEQIRUS USA INC - RP# 26- 0107 INFLUENZA VACCINE AFLURIA QUADRIVALENT FOR INMATES FLUAD, PRE-FILLED SINGL-DOSE SYRINGE (PFS), 65 YRS AND OLDER

PIID: 15B30626F00000069

Signed Date: Mar 4, 2026Effective Date: Mar 4, 2026End Date: Closes in 97 days

Award $

$233.32

Vendor

SEQIRUS USA INC

NAICS

325412

Signed Date

Mar 4, 2026

Key Details

Dollars Obligated

$233.32

Base & All Options

$233.32

Awarding Agency

Department of Justice

Awarding Sub-Agency

Federal Prison System / Bureau of Prisons

NAICS Code

325412 - PHARMACEUTICAL PREPARATION MANUFACTURING

Product Service Code

6505 - DRUGS AND BIOLOGICALS

Extent Competed

FULL AND OPEN COMPETITION

Place of Performance

SUMMIT, NJ, 079012140, CD-NJ-07

Description

RP# 26- 0107 INFLUENZA VACCINE AFLURIA QUADRIVALENT FOR INMATES FLUAD, PRE-FILLED SINGL-DOSE SYRINGE (PFS), 65 YRS AND OLDER

Context & Analysis

On Mar 4, 2026, Department of Justice obligated $233.32 to SEQIRUS USA INC for rp# 26- 0107 influenza vaccine afluria quadrivalent for inmates fluad, pre-filled singl-dose syringe (pfs), 65 yrs and older. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition. Performance is located in SUMMIT, NJ. The contract is scheduled through Sep 15, 2026 — approximately 3 months remaining.